Odyssey Therapeutics (ODTX)

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

的Odyssey Therapeutics, Inc. Common Stock（ODTX）股票的价格今天是$16.22，自市场开启。该公司市值为$7.30亿，日交易量为$317.13万股。对于关注价格走势的投资者来说，Odyssey Therapeutics, Inc. Common Stock股票今日的波动区间在$15.35和$20.18之间。前一交易日收盘价为 。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Odyssey Therapeutics股票的指南。